Cited by 98Thyroid Disorders and TreatmentsThyroid and Parathyroid SurgeryThyroid Cancer Diagnosis and Treatment

Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial

Open access
Pollock, M Anne, Sturrock, Alison, Marshall, Karen, Davidson, Kate M, Kelly, Christopher J G, McMahon, Alex D, McLaren, E Hamish·2001·BMJ

Abstract

Objectives: To determine whether thyroxine treatment is effective in patients with symptoms of hypothyroidism but with thyroid function tests within the reference range, and to investigate the effect of thyroxine treatment on psychological and physical wellbeing in healthy participants. Design: Randomised double blind placebo controlled crossover trial. Setting: Outpatient clinic in a general hospital. Participants: 25 patients with symptoms of hypothyroidism who had thyroid function tests within the reference range, and 19 controls. Methods: Participants were given thyroxine 100 µg or placebo to take once a day for 12 weeks. Washout period was six weeks. They were then given the other to take once a day for 12 weeks. All participants were assessed physiologically and psychologically at baseline and on completion of each phase. Main outcome measures: Thyroid function tests, measures of cognitive function and of psychological and physical wellbeing. Results: 22 patients and 19 healthy controls completed the study. At baseline, patients' scores on 9 out of 15 psychological measures were impaired when compared with controls. Patients showed a significantly greater response to placebo than controls in 3 out of 15 psychological measures. Healthy participants had significantly lower scores for vitality when taking thyroxine compared to placebo (mean (SD) 60 (17) v 73 (16), P<0.01). However, patients' scores from psychological tests when taking thyroxine were no different from those when taking placebo except for a poorer performance on one visual reproduction test when taking thyroxine. Serum concentrations of free thyroxine increased and those of thyroid stimulating hormone decreased in patients and controls while they were taking thyroxine, confirming compliance with treatment. Although serum concentrations of free triiodothyronine increased in patients and controls taking thyroxine, the difference between the response to placebo and to thyroxine was significant only in the controls. Conclusions: Thyroxine was no more effective than placebo in improving cognitive function and psychological wellbeing in patients with symptoms of hypothyroidism but thyroid function tests within the reference range. Thyroxine did not improve cognitive function and psychological wellbeing in healthy participants. What is already known on this topic: Recent anecdotal accounts suggest that patients with symptoms of hypothyroidism but who are biochemically euthyroid may benefit from thyroxine treatment No controlled trials in this area have been reported What this study adds: This study suggests that thyroxine is no more effective than placebo in improving psychological and physical wellbeing in patients who show symptoms of being clinically hypothyroid but whose thyroid function tests are within the reference range Thyroxine replacement did not improve psychological and physical wellbeing in healthy participants

Integrity signals

Registry

Crossref · 10.1136/bmj.323.7318.891

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Symptoms consistent with hypothyroidism in euthyroid individuals do not respond to LT4 and should not be treated with LT4.

    “It seems clear that symptoms consistent with hypothyroidism in euthyroid individuals do not respond to (nor should they be treated with) LT4.”

    From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [88]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pollock, M. A., Sturrock, A., Marshall, K., Davidson, K. M., Kelly, C. J. G., McMahon, A. D., & McLaren, E. H.
Affiliations
  • Stobhill Hospital (GB)
  • Gartnavel General Hospital (GB)
  • University of Glasgow (GB)
Corresponding author
Pollock, M Anne
Venue
BMJ
Publisher
BMJ
Published
2001-10-20
Volume
323
Issue
7318
Pages
891-895
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2087859267
Cited by
98
References
11
Citations by year
2025: 3 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 7 · 2020: 4 · 2019: 11 · 2018: 6 · 2017: 1 · 2016: 5 · 2015: 2 · 2014: 5 · 2013: 3 · 2012: 4
FWCI
3.91
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
thyroxine, hypothyroidism symptoms, euthyroid patients, placebo response, cognitive function, psychological well-being, physical well-being, vitality, free triiodothyronine, thyroid-stimulating hormone, free thyroxine, medication adherence, healthy volunteers, crossover trial
MeSH terms
Antibodies, Cholesterol, Double-Blind Method, Ferritins, Humans, Hypothyroidism, Iodide Peroxidase, Prolactin, Psychological Tests, Thyroid Function Tests, Thyroid Gland, Thyrotropin, Thyrotropin-Releasing Hormone, Thyroxine, Treatment Failure, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review